Register for the ESMO Post Show Roundtable
Highlights from the virtual conference
The clamor for more transparency from the leading pandemic vaccine contenders has been getting louder.
The role gives one of the driving forces behind Bristol Myers Squibb’s $74 billion takeover of Celgene the chance to help build biotechs.
The appointment gives Sino-American biotech Brii the experience of a man who helped Gilead launch eight drugs in China in quick succession.